2019-08-29

OBJECTS AND REASONS

This Bill would provide for

(a)

(b)

the regulation of the handling of medicinal cannabis in Barbados;

the  establishment  of  a  Barbados  Medicinal  Cannabis  Licensing
Authority,  a  Barbados  Medicinal  Cannabis  Licensing  Board  and  a
Barbados Medicinal Cannabis Appeals Tribunal;

(c)

the issuing of licences for the handling of medicinal cannabis; and

(d)

related matters.

2

Arrangement of Sections

PART I

PRELIMINARY

1.

2.

3.

4.

5.

6.

7.

8.

9.

Short title

Interpretation

PART II

BARBADOS MEDICINAL CANNABIS AUTHORITY

Establishment of Authority

Functions of the Authority

Establishment of a Board to manage Authority

Functions of the Board

Board may delegate functions

Disclosure of interest

Report to Minister

10.

Directions of Minister

11.

Chief Executive Officer and staff of the Authority

3

12.

Transfer and secondment of public officers

13.

Limitation on powers of Board

14.

Functions of the Chief Executive Officer

15.

Obligation to secrecy

16.

Protection from personal liability

17.

Funds and resources of the Authority

18.

Borrowing power

19.

Guarantee of loans

20.

Accounts

21.

Monthly statements

22.

Audit

23.

Public Finance Management Act to apply

24.

Annual Report to Minister

PART III

ACCESS TO MEDICINAL CANNABIS

25.

Use of Medicinal Cannabis

26.

Dose limitation

27.

Keeping of records

4

28.

Caregivers

29.

Dispensing of medicinal cannabis

PART IV

LICENSING THE SUPPLY OF MEDICINAL CANNABIS

30.

Categories of licences

31.

Tiers and types of licences

32.

Eligibility to apply

33.

Conditions of licences

34.

Duration of a Licence

35.

Prohibition against supply

36.

Suspension or Revocation

37.

Protection from criminal liability

PART V

BARBADOS MEDICINAL CANNABIS APPEALS TRIBUNAL

38.

Establishment of Appeals Tribunal

39.

Appeals to the Cannabis Appeals Tribunal

5

PART VI

OFFENCES

40.

Offences

41.

General Penalty

PART VII

MISCELLANEOUS

42.

Regulations

43.

Amendment of Schedule

44.

Amendment of enactments in the Third Schedule

45.

Commencement

FIRST SCHEDULE

Composition and Management of the Barbados Medicinal Cannabis Licensing
Board

SECOND SCHEDULE

Barbados Medicinal Cannabis Appeals Tribunal

THIRD SCHEDULE

Consequential Amendments

BARBADOS

A Bill entitled

An Act to provide for

(a)

(b)

the regulation of the handling of medicinal cannabis in Barbados;

the  establishment  of  a  Barbados  Medicinal  Cannabis  Licensing
Authority,  a  Barbados  Medicinal  Cannabis  Licensing  Board  and  a
Barbados Medicinal Cannabis Appeals Tribunal;

(c)

the issuing of licences for the handling of medicinal cannabis; and

8

(d)

related matters.

ENACTED by the Parliament of Barbados as follows:

PART I

PRELIMINARY

Short title

1.

This Act may be cited as the Medicinal Cannabis Industry Act, 2019.

Interpretation

2.(1)

In this Act,

“Authority”  means  the  Barbados  Medicinal  Cannabis  Licensing  Authority

established under section 3;

“analytical services” includes services for the testing or abstraction of cannabis;

“Board” means the Barbados Medicinal Cannabis Licensing Board which is the

Board of the Authority established under section 5;

“cannabis” means all parts of any plant of the genus cannabis including any resin

obtained from the plant;

“cannabis material” means

(a)

(b)

(c)

cannabis;

cannabis resin; and

any other raw material derived from the cannabis plant;

“cannabis resin” has the meaning assigned to it in the Drug Abuse (Prevention

and Control) Act, Cap. 131;

9

“cannabidiol” or “CBD” means a substance found in the cannabis plant which
reacts  with  specific  receptors  in  the  human  brain  and  body  to  give  a
therapeutic effect;

“CARICOM Member States” or “CARICOM” means the countries or territories
which  are  party  to  the  Revised  Treaty  of  Chaguaramas  establishing  the
Caribbean  Community,  as  well  as  the  CARICOM  Single  Market  and
Economy, that was signed in the Bahamas on 5th July, 2001;

“controlled drug” has the meaning assigned to it by section 3 of the Drug Abuse

(Prevention and Control) Act, Cap. 131;

“cultivation” includes harvesting, curing and drying;

“cultivation  site”  means  the  premises  specified  in  a  Cultivator  Licence  as

premises on which cannabis plants are authorised to be cultivated;

“dispose” means the procedures for destroying cannabis;

“document”  means,  in  addition  to  a  document  in  writing,  anything  in  which

information of any description is recorded;

“handling”  includes  use,  cultivation,  processing,  importation,  exportation,
transit, transshipment, manufacture, sale, possession and distribution;

“harvest”  means  the  process  of  gathering  every  plant  that  is  reaped,  whether
manually  or  by  way  of  machinery,  whether  or  not  that  plant  is  dead  or
deemed to have no commercial value or viability;

“licence” means a licence issued to a person by the Authority to facilitate the
handling of medicinal cannabis or research and development of cannabis in
accordance with the Act to supply medicinal cannabis;

“medical,  therapeutic  or  scientific  purposes”  includes  scientific  research,
research  trials,  clinical  trials,  therapy  and  treatment,  and  manufacture  of
nutraceuticals and pharmaceuticals;

“medicinal cannabis” means

(a)

cannabis that is grown and sold pursuant to this Act;

10

(b)

(c)

seeds, immature plants as well as all parts of the plant, along with resin
extracted from any part of the plant ;

every compound, manufacture, salt, derivative, mixture or preparation
from cannabis;or

(d)

cannabis concentrate;

that  is  cultivated,  processed,  manufactured,  distributed  or  sold  under  a
licence.

“medical practitioner ” has the meaning assigned to it by section 2 of the Medical

Profession Act, 2011 (Act 2011 - 1);

“Minister” means the Minister responsible for Agriculture and Food Security;

“minor” means a person who is a patient and who is under the age of 18 years;

“patient” means a person who suffers from a medical condition which may be
treated with medicinal cannabis prescribed or recommended pursuant to this
Act;

“pharmacist” has the meaning assigned to it by section 2 of the Pharmacy Act,

Cap. 372D;

“pharmacy” means a place registered as a pharmacy under the Pharmacy Act,

Cap. 372D;

“premises” means any land or building as well as any vehicle or receptacle located

on such land or in any such building;

“public officer” has the meaning assigned to it by section 2 of the Public Service

Act, Cap. 29;

“recommendation”  means  a  written  recommendation  dispensing  cannabis  for

medical purposes;

“tetrahydrocannabinol” or “THC” means the main active ingredient in cannabis
and  one  of  the  many  naturally  occurring  chemical  compounds  found  in
cannabis;

11

“Tribunal” means the Barbados Medicinal Cannabis Tribunal established under

section 38;

“therapeutic facility” means a premises granted a Retail Distributor Licence to

(a)

(b)

sell,  dispense  or  provide  medicinal  cannabis  prescribed  or
recommended by a medical practitioner; and

provide facilities and other medicinal or therapeutic requirements to
allow  a  patient  who  has  purchased  prescribed  or  recommended
medicinal cannabis to use or consume that medicinal cannabis there
for therapeutic purposes;

“visitor” means a person who is

(a)

(b)

(c)

a patient

is not a resident of Barbados; and

is in possession of a prescription or written recommendation from a
medical practitioner in respect of medicinal cannabis;

“young person” means a person who is a patient and who is under the age of 21

years;

The  provisions  of  the  Drug  Abuse  (Prevention  and  Control)  Act,
(2)
Cap.  131,  and  the  Proceeds  and  Instrumentalities  of  Crime  Act,  2019
(Act 2019-17) shall not prohibit, or otherwise be applied to the use of medicinal
cannabis or cannabis pursuant to this Act, or be used to restrict or render unlawful,
the  handling  of  medicinal  cannabis  or  cannabis  by  any  person,  unless  it  is  in
accordance with the provisions of this Act.

12

PART II

BARBADOS MEDICINAL CANNABIS AUTHORITY

Establishment of Authority

3.(1)
Medicinal Cannabis Licensing Authority.

There  is  hereby  established  a  body  to  be  known  as  the  Barbados

The Authority is a body corporate to which, subject to section 17, section 21

(2)
of the Interpretation Act, Cap. 1 applies.

Functions of the Authority

4.(1)

The Authority shall

(a)

develop policies, procedures and guidelines to establish the medicinal
cannabis industry and to ensure that medicinal cannabis is available to
patients in a safe and efficient manner;

(b)

regulate the handling of medicinal cannabis;

(c)

(d)

subject to subsection (2), issue licences in relation to the handling of
medicinal cannabis in accordance with the provisions of this Act;

develop  enforcement  procedures  in  relation  to  the  inspection  of
premises that are operated by a person in order to ensure compliance
with the provisions of this Act or any regulations made pursuant to this
Act;

(e)

where required, assist with the provision of analytical services;

(f)

with the approval of the Board, establish and maintain an electronic
database to

(i)

include  information  relating  to  persons  who  handle  medicinal
cannabis or cannabis in accordance with this Act; and

13

(ii)

provide for the electronic tracking of the handling of medicinal
cannabis or cannabis in accordance with this Act;

with the approval of the Board establish and maintain an electronic
register of medical practitioners, patients and caregivers, in accordance
with this Act and such other registers as may be prescribed;

provide for the distribution of educational materials and the conduct
of  training  programmes  in  relation  to  the  development  and  use  of
medicinal cannabis and the medicinal cannabis industry;

ensure  that  proper  disposal  requirements  are  prescribed  for  the  safe
disposal of cannabis which is handled under this Act;

perform such other functions assigned to it under this Act or any other
enactment; and

enter into any arrangement, which, in the opinion of the Authority, is
necessary to ensure the proper performance of its functions.

(g)

(h)

(i)

(j)

(k)

(2)

In performing the functions specified in subsection (1) , the Authority shall

(a)

(b)

(c)

formulate standards and prescribe codes of practice to be observed by
licensees or other persons involved in the medicinal cannabis industry;

determine the fees to be charged for services provided by or on behalf
of the Authority;

facilitate scientific research in respect of medicinal cannabis and where
applicable, apply the results of such research in the development of the
medicinal cannabis industry; and

(d)

do all such things as the Authority considers necessary or expedient
for the purpose of carrying out its functions.

14

Establishment of a Board to manage Authority

5.(1)
There  shall  be  established  a  Board,  to  be  known  as  the  Barbados
Medicinal Cannabis Licensing Board, which shall be responsible for the policy,
organisation and administration of the Authority, and in particular for

(a)

(b)

(c)

(d)

the appointment of staff to the Authority and the management thereof;

the management of the other resources and contracts of the Authority;

the development of policies for the prudent and efficient management
of the Authority; and

the monitoring of the performance of the Authority in respect of the
discharge of its functions.

The  First  Schedule  has  effect  with  respect  to  the  constitution  and

(2)
management of the Board and otherwise in relation thereto.

Functions of the Board

6.(1)
governance of the Authority.

The Board shall be responsible for the policy, strategic direction and

(2)

In performing its functions, the Board shall

(a)

(b)

(c)

(d)

monitor the administrative operations of the Authority;

advise  the  Minister  on  matters  of  general  policy  relating  to  the
management, and development of an efficient and regulated medicinal
cannabis industry;

ensure that the Authority receives and manages its funds in a prudent
manner; and

do  all  such  things  as  the  Board  reasonably  considers  necessary  or
expedient for the purpose of carrying out its functions under this Act.

15

Board may delegate functions

7.(1)
The Board may delegate to the Chairman, a committee of the Board
or the Chief Executive Officer of the Authority such of its functions as it thinks
expedient for the purpose of effectively transacting the business of the Board .

(2)

A delegation of a function under subsection (1)

(a)

(b)

does not prevent the discharge by the Board of the function; and

may, at any time, be revoked by the Board.

Disclosure of interest

A  member  of  the  Board  who  is  in  any  way  directly  or  indirectly
8.(1)
interested in any contract or other matter whatsoever which falls to be considered
by the Board, or in any contract made or proposed to be made by the Board, shall
disclose the nature of his interest to the other members of the Board at a meeting
of the Board, and the disclosure shall be recorded in the minutes taken at that
meeting of the Board, and that member shall not take part in any deliberation or
decision of the Board relating to the contract.

A disclosure made by a member of the Board under subsection (1), to the
(2)
effect  that  he  is  a  director  or  shareholder  of,  or  has  a  significant  economic
relationship with a specific company, firm or other person or is to be regarded as
interested in any contract which is made with the company, firm or other person
shall, for the purposes of subsection (1), be a sufficient disclosure of his interest
in relation to any contract so made.

Report to Minister

9.
The Board may at any time, be required by the Minister to submit a
report in respect of any matter or activity in which the Authority is involved under
this Act.

16

Directions of Minister

The Minister may give directions of a general nature as to the policy
10.
to  be  followed  by  the  Board  and  the  Authority  in  the  performance  of  their
functions, as appear to the Minister to be necessary in the public interest, and the
Board and the Authority shall comply with those directions.

Chief Executive Officer and staff of the Authority

11.(1)
to be the Chief Executive Officer of the Authority.

The Board shall, with the approval of the Minister, appoint a person,

(2)

The Chief Executive Officer

(a)

(b)

shall hold office for a term not exceeding 3 years, but is eligible for
reappointment; and

is  entitled  to  such  remuneration  and  allowances  as  the  Minister
determines.

The Board shall, with the approval of the Minister, appoint or employ such

(3)
other members of staff as may be required for the Authority.

The  staff  of  the  Authority  shall  receive  such  remuneration  and  such

(4)
allowances as the Minister may determine.

Transfer and secondment of public officers

12.(1)
Where a public officer is seconded to a post in the Authority from a
pensionable  office  within  the  meaning  of  section  2  of  the  Pensions  Act,
Cap. 25, the period of service with the Authority, unless the Governor-General
otherwise determines, counts for pension under that Act as if the officer had not
been so seconded.

17

Where a public officer accepts employment with the Authority, the public

(2)
officer shall

(a)

(b)

be employed on terms and conditions that are no less favourable than
those enjoyed by a public officer of proximate rank or a public officer
performing comparable duties; and

retain any right to pension, gratuity or other allowance for which he
would have been eligible had he remained in the public service and any
such right is preserved.

Limitation on powers of Board

13.

The Board shall not, without the prior approval of the Minister,

(a)

(b)

assign to a post established by the Board a salary in excess of such
amount  per  annum  as  the  Minister  may  determine  and  notify  the
Authority in writing;

appoint a person to a post established by the Board to which a salary
in  excess  of  the  amount  determined  by  the  Minister  under
paragraph (a) is assigned; or

(c)

provide for the payment of a pension, gratuity or similar benefit to the
staff of the Authority in respect of their service to the Authority.

Functions of the Chief Executive Officer

14.(1)
management of the affairs of the Authority which shall include the following

The Chief Executive Officer shall be responsible for the day to day

(a)

(b)

coordinating the functions of the Authority;

the taking of any administrative and managerial action as is necessary
and appropriate for the effective implementation of this Act and any
regulations made pursuant to this Act;

18

(c)

(d)

(e)

(f)

(g)

(h)

assigning personnel as may be necessary to ensure that applications for
licences are submitted to the Board for approval within the prescribed
period after the making thereof;

ensuring the timely implementation of the decisions and directions of
the Board;

submitting quarterly reports to the Board in relation to the activities of
the Authority, in such manner as may be approved by the Board;

preparing the budget of the Authority and submitting the same to the
Board for approval;.

implementing  operational  policies  and  procedures  in  relation  to  the
functions of the Authority; and

performing  such  other  functions  as  may  be  assigned  to  the  Chief
Executive Officer by the Board or under this Act.

The Chief Executive Officer shall attend the meetings of the Board, but

(2)
shall not have a vote at any meeting of the Board.

Obligation to secrecy

15.(1)
Every  person  having  an  official  duty  or  being  employed  in  the
administration of this Act shall regard and deal with as secret and confidential
all  information,  databases,  registers,  records  or  documents  relating  to  the
functions of the Authority or the Board obtained by the person in the course of
the performance of his duties or otherwise.

Notwithstanding subsection (1) a person may disclose information in any

(2)
of the following circumstances

(a)

(b)

pursuant to an order of the Court;

to any person or to an employee of the Authority, where he is authorised
or required to do so; or

(c)

where disclosure is permitted under any other enactment.

19

A  person  who  receives  information  pursuant  to  subsection(2)(a)  shall

(3)
regard and deal with that information as confidential.

(4)
A person who contravenes subsection (1) or (2) is guilty of an offence and
is liable on summary conviction to a fine of $10 000 or to imprisonment for a
term of 2 years.

Protection from personal liability

16.
No action, suit, prosecution or other proceedings shall be brought or
instituted personally against any member of the Board or Tribunal, employee or
agent  of  the  Authority  in  respect  of  any  Act  done  bona  fide  in  pursuance  or
execution of the Act.

Funds and resources of the Authority

17.(1)

The funds and resources of the Authority shall comprise

(a)

(b)

(c)

monies voted for the purpose by Parliament;

such sums as may be borrowed by the Authority for its purposes; or

revenue earned from application fees, fees for the issuing of licences
and other related matters.

The  resources  of  the  Fund  shall  be  applied  in  the  payment  of  salaries,
(2)
payment or discharge of the expenses, obligations and liabilities of the Authority,
the Board and the Tribunal and towards the performance of any function of the
Authority, the Board or the Tribunal under this Act.

Borrowing power

The  Authority  may,  with  the  approval  of  the  Minister,  borrow  any
18.
money  it  requires  for  meeting  any  of  its  obligations  or  performing  any  of  its
functions and shall, in such a case, inform the Minister of

(a)

(b)

the amount and source of the loan; and

the terms and conditions on which the loan may be obtained.

20

Guarantee of loans

In circumstances where approval under section 18 requires a guarantee
19.
the Government may, with the approval of Parliament, in such manner and on
such terms and conditions as may be specified, guarantee a loan to the Authority
together with any interest or other charges payable thereon.

Accounts

20.

The Authority shall, in respect of its affairs and functions,

(a)

(b)

keep proper accounts and adequate financial and other records; and

prepare financial statements in respect of each financial year,

in conformity with generally accepted accounting practice.

Monthly statements

Every month the Chief Executive Officer shall prepare and submit to
21.
the  Accountant-General  within  such  time  as  the  Accountant-General  may
determine

(a)

a  statement  of  revenue  showing,  under  such  headings  as  the
Accountant-General may determine, the total revenue earned;

(b)

a statement of cash flows; and

(c)

a statement of refunds, remittances and waivers made,

during the preceding month.

Audit

22.(1)

The Auditor-General shall be the auditor of the Authority.

(2)

The Auditor-General shall

(a)

audit annually, the accounts of the Authority and report to the Authority
and the Minister on the financial statements of the Authority;

21

(b)

periodically  assess,  on  such  basis  as  the  Auditor-General  may
determine  to  be  reasonable,  the  fairness  and  reliability  of  the
information submitted to him by the Authority; and

(c)

provide the Minister and the Authority with copies of reports of audits
and assessments carried out under this section.

Public Finance Management Act to apply

23.
the Authority with such modifications and adaptations as may be necessary.

The Public Finance Management Act, 2019 (Act 2019-1) applies to

Annual Report to Minister

24.(1)
year, submit to the Minister an annual report including

The Board shall, not later than 3 months after the end of every financial

(a)

(b)

(c)

information on the execution of its functions, and the functions of the
Authority over the period;

an account of the activities and transactions of the Authority throughout
the financial year in such detail as the Minister may direct; and

a  detailed  statement  of  all  sums  remitted  in  accordance  with  the
the  Public  Finance  Management  Act,  2019
provisions  of
(Act 2019-1).

The Board may include in its annual report mentioned in subsection (1)
(2)
matters which, in the opinion of the Board, require the attention of the Minister.

22

PART III

ACCESS TO MEDICINAL CANNABIS

Use of Medicinal Cannabis

A  person  or  visitor  shall  only  use  medicinal  cannabis  where  that
25.(1)
medicinal  cannabis  is  prescribed  by  a  medical  practitioner  or  required  by  a
recommendation by a medical practitioner.

The parent or guardian of a patient who is a minor or young person must
(2)
obtain a certificate in writing from a medical practitioner certifying that the use
of medicinal cannabis is necessary in the case of that minor or young person, and
the parent or guardian shall consent in writing to the use of medicinal cannabis.

A person who consumes medicinal cannabis without being authorised to
(3)
use  medicinal  cannabis  by  a  prescription  or  recommendation  from  a  medical
practitioner is guilty of an offence and is liable on conviction on indictment to a
fine of $100 000 or to imprisonment for a term of 10 years or to both.

Dose limitation

26.
In  circumstances  where  a  prescription  or  recommendation  by  a
medical  practitioner  requires  repeated  usage  over  a  period  of  3  months,  a
pharmacy or therapeutic facility shall not dispense to that patient more than a 30
day supply of individual doses at a time.

Keeping of records

27.(1)
A  medical  practitioner  shall  maintain  a  record  of  every  patient  to
whom he has prescribed or recommended medicinal cannabis, and where that
patient has a caregiver the medical practitioner shall also enter into the record the
name, national registration number and contact information for the caregiver.

All information acquired by the medical practitioner under subsection (1)
(2)
is confidential, but the medical practitioner shall submit to the Authority at such

23

times as the Authority may direct a report containing such information, excluding
the name of the patient, address of the patient, or the national registration number
of his patient, from his records as the Authority may prescribe.

The  Authority  may  request  further  information  from  the  medical

(3)
practitioner in writing.

Caregivers

28.(1)
as a caregiver and that person has the responsibility

Subject to subsections (2) and (3), a patient may designate a person

(a)

(b)

(c)

for the immediate care and safety of the patient;

to assist him with obtaining or using medicinal cannabis; or

to act in the best interest of that person.

A guardian appointed for a person by the Court under the Mental Health

(2)
Act, Cap. 45 shall be deemed to be the caregiver of that person.

A parent or legal guardian of a patient who is a minor or young person shall
(3)
be deemed to be the caregiver for that minor or young person unless that parent
or legal guardian designates another person or a person is designated by an order
of the Court.

A person who is designated as a caregiver under this Act shall obtain from
(4)
a medical practitioner a certificate that states that the caregiver is not addicted to
a controlled drug.

A person who is under the age of 18 years shall not be designated as a

(5)
caregiver.

A caregiver shall not be a person who has been convicted of an indictable

(6)
offence under the Drug Abuse (Prevention and Control) Act, Cap. 131.

A patient who changes his caregiver shall notify his medical practitioner
(7)
of the change, and give that medical practitioner such information as the medical
practitioner may require in respect of the new caregiver.

24

Dispensing of medicinal cannabis

29.(1)
A  pharmacist  or  authorised  personnel  under  the  supervision  of  a
pharmacist  in  a  pharmacy  or  a  pharmacist  or  authorised  personnel  under  the
supervision  of  a  pharmacist  in  a  therapeutic  facility  may  dispense  medicinal
cannabis to a patient and where applicable, to a caregiver for a patient.

Subject  to  subsection  (1),  a  pharmacist  or  authorised  person  being
(2)
supervised by a pharmacist shall only dispense or supply medicinal cannabis on
the submission by a patient or where applicable, a caregiver, of a prescription
or recommendation and a valid form of identification.

Upon dispensing medicinal cannabis to a patient or, where applicable, a
(3)
caregiver, a pharmacist or other authorised personnel under the supervision of a
pharmacist shall ensure that the label given in respect of the prescription or the
recommendation has the information required by regulation 3(2) of the Pharmacy
(Compounding  and  Dispensing  of  Drugs  and  Poisons)  Regulations,  1986
(S.I. 1986 No. 82).

A pharmacist shall enter the information referred to in subsection (3) in a
(4)
register kept by him and established for that purpose, in the prescribed manner.

A  pharmacist  shall  not  dispense  to  a  patient  or  where  applicable,  a

(5)
caregiver

(a)

a quantity of medicinal cannabis greater than that which the patient or
caregiver is permitted to obtain under a prescription; or

(b)

any form of cannabis prohibited under this Act or any other enactment.

A pharmacist shall conform to any requirement or limitation set by the
(6)
medical  practitioner  as  to  the  form  of  medicinal  cannabis  that  is  required  in
relation  to  the  patient  and  shall  provide  to  a  patient  and  where  applicable,  a
caregiver, the following information

(a)

the lawful methods for administering medicinal cannabis in individual
doses;

25

(b)

any potential danger stemming from the use of medicinal cannabis;

(c)

(d)

how to prevent or deter the misuse of medicinal cannabis by minors or
young persons; and

any  other  information  which  the  pharmacist  may  consider  to  be
relevant.

PART IV

LICENSING THE SUPPLY OF MEDICINAL CANNABIS

Categories of licences

30.
cannabis industry for the

Licences may be issued in respect of the development of the medicinal

(a)

(b)

(c)

cultivation of cannabis for medicinal purposes;

transporting of medicinal cannabis;

manufacturing of medicinal cannabis products;

(d)

dispensing of medicinal cannabis at a therapeutic facility;

(e)

sale of medicinal cannabis;

(f)

(g)

(h)

(i)

research  and  development  of  cannabis  for  medical  therapeutic  or
scientific purposes;

laboratory testing of medicinal cannabis;

importing of medicinal cannabis; and

exporting of medicinal cannabis.

26

Tiers and types of licences

31.(1)
cannabis industry may apply for any of the following licences

A person who desires to obtain a licence to operate in the medicinal

(a)

(b)

(c)

(d)

(e)

(f)

(g)

a Cultivator Licence (Tier 1), Cultivator Licence (Tier 2), Cultivator
Licence (Tier 3) and Cultivator Licence (Tier 4) which shall be issued
to  allow  for  the  growing,  harvesting,  drying,  trimming,  curing  or
packaging of medicinal cannabis;

a Research and Development Licence, which shall be issued to allow
for the conduct of scientific research for the purpose of improving or
further  developing  cannabis  for  medical,  therapeutic  or  scientific
purposes;

a Laboratory Licence which shall be issued to allow for the conduct of
testing and analytical services for the purpose of improving or further
developing medicinal cannabis;

a Processor Licence (Tier 1), Processor Licence (Tier 2), and Processor
Licence (Tier 3)  which shall be issued to allow for activities relating
to  the  processing  and  manufacturing  of  cannabis  material  and
medicinal cannabis products;

a  Retail  Distributor  Licence,  which  shall  be  issued  to  allow  for  the
operation  of  a  therapeutic  facility  for  the  dispensing  of  medicinal
cannabis to patients;

an Import Licence, which shall be issued to allow for the importation
of medicinal cannabis products and planting material from any country
where it is legal so to do;

an Export Licence, which shall be issued to allow for the exportation
of medicinal cannabis to any country in keeping with the laws of any
such country; and

27

(h)

a Transport Licence, which shall be issued to allow for the transport of
medicinal cannabis.

(2)

Where a person applies for a

(a)

(b)

Research and Development Licence; or

Laboratory Licence

and  the  licence  is  issued,  that  person  shall  also  receive  an  import  and  export
licence which shall only be used for purposes in connection with the Research
and Development Licence or the Laboratory Licence.

(3)

(4)

A licence issued pursuant to this Act shall not be transferable.

In respect of a Cultivator Licence the area of land for

(a)

(b)

(c)

Tier 1 shall be not more than 1 acre;

Tier 2 shall be more than 1 acre but not more than 5 acres; and

Tier 3 shall be more than 5 acres but not more than 25 acres;

(d)

Tier 4 shall be more than 25 acres.

(5)

In respect of a Processor Licence, the processing area for

(a)

(b)

Tier 1 shall be not more than 200 square metres; and

Tier 2 shall be more than 200 square metres but not more than 500
square metres; and

(c)

Tier 3 shall be more than 500 square metres.

Eligibility to apply

32.(1)

A person who

(a)

(b)

(c)

is 18 years of age or older;

is a citizen of Barbados;

is a permanent resident of Barbados;

28

(d)

has immigrant status in Barbados;

(e)

is a citizen of a CARICOM Member State, other than Barbados; or

(f)

is a company, partnership or co-operative society

may apply for a licence.

An application for a licence under subsection (1) shall be accompanied by

(2)
a certificate from a medical practitioner that states

(a)

(b)

in  the  case  of  an  individual,  that  the  individual  is  not  addicted  to  a
controlled drug; or

in the case of a partnership, that a member is not addicted to a controlled
drug.

(3)

A person who has been convicted of an indictable offence under

(a)

(b)

(c)

the Drug Abuse (Prevention and Control) Act , Cap. 131;

the  Proceeds  and  Instrumentalities  of  Crimes  Act,  2019  (Act  2019
-17); or

any other similar enactment creating offences for illegal drugs and for
the proceeds gained from such illegal drugs in Barbados or in any other
country

shall not be eligible for a licence.

A person to whom subsection (1)(f)   applies that person shall not be eligible
(4)
for  a  licence  unless  30  per  cent  of  the  company,  partnership,  or  co-operative
society is owned by a citizen, permanent resident, person with immigrant status
or a citizen of a CARICOM Member State  .

Subsection (4) shall not apply to a Research and Development Licence or

(5)
a Laboratory Licence.

The Authority shall prescribe regulations in relation to the criteria for the

(6)
eligibility to apply for each category of licence.

29

Conditions of licences

33.
impose conditions in respect of the issue of licences.

The  Minister  on  the  advice  of  the  Authority  shall  by  regulations

Duration of a Licence

34.(1)
and is not renewable.

A Cultivator Licence, irrespective of the Tier, shall be valid for 3 years

(2)

All other licences shall be valid for 3 years and are not renewable.

A person who holds a licence under subsection (1) or (2) may, not later
(3)
than 3 months before the expiration of the licence, re-apply for the issue of a new
licence.

Prohibition against supply

A  person  shall  not  cultivate,  supply,  possess,  or  obtain  medicinal
35.(1)
cannabis for any of the purposes specified under this Act, unless that person is
the holder of the relevant licence issued pursuant to this Act.

A person who contravenes subsection (1) is guilty of an offence and is
(2)
liable on conviction on indictment to a fine of 15 times the value of the medicinal
cannabis cultivated, supplied, possessed, or obtained or to imprisonment for a
term of 10 years or to both.

Suspension or Revocation

36.

The Authority may suspend or revoke a licence where the

(a)

(b)

(c)

person issued the licence is convicted of an offence under this Act;

person issued the licence contravenes a term or condition of a licence
granted under this Act; or

Minister  requires  the  suspension  or  revocation  of  the  licence  in  the
interest of public health or public safety.

30

Protection from criminal liability

A person who is authorised to undertake any activity under this Act
37.
is  hereby  protected  from  criminal  liability,  to  the  extent  that  the  activity  is
authorised by, and conducted in accordance with, the provisions of this Act .

PART V

BARBADOS MEDICINAL CANNABIS APPEALS TRIBUNAL

Establishment of Appeals Tribunal

38.(1)
Tribunal, hereinafter called the Tribunal.

There is hereby established a Barbados Medicinal Cannabis Appeals

The  provisions  of  the  Second  Schedule  shall  have  effect  as  to  the

(2)
constitution and operation of the Tribunal and otherwise in relation thereto.

The Tribunal may, with the approval of the Minister, make rules to regulate

(3)
its own procedure, including provision for any fees to be charged.

Appeals to the Cannabis Appeals Tribunal

39.(1)
A person who is aggrieved by a decision of the Authority or any other
person acting in exercise of any function delegated under this Act, may appeal
to the Tribunal by way of a notice of appeal within 14 days of the date of the
decision  or  within  such  longer  period  as  the  Tribunal  may,  in  any  special
circumstance, allow.

The notice of appeal shall set out clearly the grounds of the appeal and
(2)
shall be accompanied by copies of any correspondence, document or statement
relevant to the appeal.

A copy of the notice of appeal, together with copies of any correspondence,

(3)
document or statement shall be served on the Authority.

31

(4)
The Tribunal shall, within 14 days of the receipt of a notice of appeal under
subsection  (1),  request  the  Authority  to  furnish  it  with  a  statement  in  writing
setting  out  the  reasons  for  its  decision  and  within  14  days  of  receipt  of  the
statement, a copy of the statement shall be served on the appellant.

The  Tribunal  may  order  that  any  book,  paper,  document  or  statement,
(5)
relating to the appeal which is in the possession of the Authority, any other person
acting in accordance with this Act, or the person aggrieved, be produced at the
hearing of the appeal.

(6)

The Tribunal shall cause all parties to the appeal to be informed

(a)

of the date of the hearing of the appeal, which shall be within 30 days
from the date on which the statement is served on the appellant pursuant
to subsection (4);

(b)

that they may appear in person or be represented by an attorney-at-law;
and

(c)

that they may call witnesses on their behalf.

(7)

On hearing an appeal under this section, the Tribunal may

(a)

(b)

(c)

dismiss the appeal and confirm the decision of the Authority;

allow the appeal and set aside the decision of the Authority; or

direct that the matter be referred to the Authority.

32

PART VI

OFFENCES

Offences

40.(1)

No person shall

(a)

(b)

(c)

(d)

sell, offer for sale or offer for free distribution, medicinal cannabis,
cannabis or any derivatives or samples thereof at any convention, trade
show or at a public or private event;

have  medicinal  cannabis  in  his  possession,  if  that  person  is  not  a
caregiver or authorised to use or licensed to use medicinal cannabis
under this Act;

allow another person who is not authorised to use medicinal cannabis
under this Act to use medicinal cannabis; or

make a misrepresentation in relation to a medical condition to a medical
practitioner  or  fraudulently  provide  material  misinformation  to  the
medical  practitioner
to  obtain  a  prescription  or
recommendation for medicinal cannabis.

in  order

A patient or caregiver shall not knowingly obtain, seek to obtain, or have
(2)
in their possession, individually or collectively, an amount of medicinal cannabis
from a pharmacy or therapeutic facility that would cause either the patient or the
caregiver  to  exceed  the  prescribed  or  recommended  amount  that  they  are
authorised to have in their possession.

A patient or caregiver who sells medicinal cannabis that is obtained under
(3)
a  prescription  or  recommendation  issued  pursuant  to  this  Act  is  guilty  of  an
offence.

(4)

A person who contravenes this section is guilty of an offence.

33

General Penalty

A person who is guilty of an offence under this Act for which no other
41.
penalty is provided, is liable on conviction on indictment to a fine of 15 times
the value of the medicinal cannabis or to imprisonment for a term of 10 years or
to both.

PART VII

MISCELLANEOUS

Regulations

The  Minister  shall,  with  the  approval  of  the  Authority,  make
42.(1)
regulations for any matter that is required or permitted to be prescribed and for
carrying out or giving effect to this Act.

(2)

Without limiting the generality of subsection (1), regulations may

(a)

(b)

(c)

prescribe  standards  for  the  supply  of  medicinal  cannabis  and  the
systems for certification to meet these prescribed standards;

prescribe fees for the application of a licence and fees for the granting
or issuing of a licence;

prescribe the documents required for an application and procedures for
maintaining the confidentiality of information contained in application
forms;

(d)

prescribe fees for administrative costs, where required;

(e)

prescribe application forms and the form of licences;

(f)

regulate, restrict or prohibit premises, vehicles or equipment used or
intended to be used for or in connection with the supply of medicinal
cannabis;

34

(g)

(h)

(i)

(j)

(k)

prescribe the category of person who can apply for each type of licence;

regulate or prohibit the transport of medicinal cannabis, including in
relation to specific areas in Barbados;

prescribe matters to be considered by the Authority in relation to the
suitability of premises for the supply of medicinal cannabis;

prescribe  standards  or  requirements  as  to  the  security  of  access  to
premises and for securing the premises in which medicinal cannabis
is supplied or cultivated;

prescribe  requirements  for  signage  at  premises  licensed  in  the
prescribed manner and information to be displayed at those premises,
or on equipment or vehicles used for or in connection with the supply
of medicinal cannabis;

(l)

prescribe the manner in which inspections, searches, detentions and
seizures under this Act are to be carried out;

(m)

prescribe documents to be kept in relation to medicinal cannabis;

(n)

(o)

(p)

(q)

(r)

prescribe the information to be submitted to the Authority in annual
reports to be submitted by a medical practitioner;

prescribe  the  sale,  supply  and  safe  custody,  storage  and  security  of
medicinal cannabis;

prescribe the procedure for dispensing medicinal cannabis to visitors
who have a medical condition;

prescribe the zoning of designated areas to be used as cultivation sites
or in connection with the supply of medicinal cannabis; and

prescribe  generally,  any  other  matter  or  thing  that  is  authorised  or
required to be prescribed by this Act.

(3)

Regulations may be made with respect to

35

(a)

prohibiting, regulating or controlling the supply, distribution, use, safe
custody and storage of medicinal cannabis;

(b)

preventing the improper use of medicinal cannabis;

(c)

(d)

(e)

(f)

(g)

(h)

(i)

prescribing the manner in which cannabis is to be disposed of;

prohibiting  or  regulating  the  issuing  of  medicinal  cannabis  by
pharmacists to patients;

requiring persons engaged in the supply of medicinal cannabis to keep
records and provide information in writing or otherwise;

the  custody,  accumulation,  destruction,  disposal,  use,  supply  and
storage of medicinal cannabis, including,

(i)

the specifications of cupboards and other receptacles; and

(ii)

the manner of storage of any form of medicinal cannabis;

regulating the supply of medicinal cannabis to persons who have had
a history of substance abuse;

regulating and controlling the advertising by any person of medicinal
cannabis, including the form and content of advertisements;

prohibiting or regulating the supply of medicinal cannabis, whether by
wholesale or by retail, or any class of products, unless the product or
class  of  product  is  packaged  in  accordance  with  regulations  and
contains  no  more  than  a  specified  concentration  of  cannabidiol  or
tetrahydrocannabinol;

(j)

the  minimum  size  of  packages  or  containers  in  which  medicinal
cannabis or any class of medicinal cannabis may be supplied or offered
for supply;

(k)

specifying the containers in which medicinal cannabis maybe supplied
and prohibiting the use of those containers for other substances;

36

(l)

(m)

labelling and specifying the particulars to be included in labels attached
to containers of medicinal cannabis;

the  inspection  of  premises,  other  than  residential  premises,  mobile
facilities, stocks, records and any other documents relating to medicinal
cannabis; or

(n)

the administration and use of medicinal cannabis.

Any  regulations  made  under  this  section  shall  be  subject  to  negative

(4)
resolution.

Where  the  regulations  made  under  this  Act  create  an  offence,  the
(5)
regulations may provide for such offences to be   tried summarily or on indictment
and the  regulations may  prescribe the following penalties

(a)

(b)

in  the  case  of  an  offence  triable  summarily,  a  fine  of  $500  000  or
imprisonment for a term of 5 years or to both;

in the case of an offence triable on indictment, a fine of $1 000 000 or
imprisonment for a term of 10 years or to both.

Amendment of Schedule

43.(1)
Gazette amend, revoke or vary the provisions of the Schedule to this Act.

The Minister may, from time to time, by order published in the Official

(2)

An order made under subsection (1) shall be subject to negative resolution.

Amendment of enactments in the Third Schedule

44.
amended in the manner specified in the second column of the Third Schedule

The enactments specified in the first column of the Third Schedule are

Commencement

45.
Proclamation.

This  Act  shall  come  into  operation  on  a  date  to  be  fixed  by

37

FIRST SCHEDULE

Composition and Management of the Barbados Medicinal Cannabis Licensing
Board

(Section 5)

Appointment of members

1.(1)
instrument in writing.

The Board shall comprise 7 members appointed by the Minister by

(2)

The Minister shall appoint as members of the Board persons from

(a)

any of the following disciplines:

(i)

banking:

(ii)

sociology;

(iii)

agriculture;

(iv)

pharmacology; or

(v)

medicine; and

(b)

from the members of the Clergy, staff of the University of the West
Indies, or members of youth organizations.

(3)

A member shall, subject to the provisions of this Schedule,

(a)

(b)

hold office for a term not exceeding 3 years; and

be eligible for reappointment.

Chairman

2.

The Minister shall appoint a member to be Chairman.

38

Resignation

3.(1)
addressed to the Minister.

The  Chairman  may  resign  his  office  by  instrument  in  writing

(2)
A member, other than the Chairman, may resign his office by instrument
in writing addressed to the Chairman, who shall forthwith forward the instrument
to the Minister.

A resignation takes effect from the date on which the Minister receives the

(3)
instrument.

Temporary leave of absence

4.

The Minister may, in writing, grant a leave of absence to a member.

Temporary appointment

Where a member is, or is likely to be, unable to perform the functions
5.
of his office for more than 30 days, whether as a result of absence from Barbados,
illness or other cause or reason, the Minister may appoint a person to act in the
place of the member.

Revocation of appointment

6.

The Minister shall revoke the appointment of a member who

(a)

(b)

(c)

fails to carry out any of his functions under this Act;

becomes of unsound mind or becomes permanently unable to perform
his functions by reason of ill health;

is convicted of an offence involving fraud or dishonesty or, in the case
of any other offence, is sentenced to a term of imprisonment;

(d)

is guilty of serious misconduct in relation to his functions;

(e)

is bankrupt or compounds with or suspends payment to his creditors;
or

39

(f)

fails to declare his interest in a matter before the Board as required by
this Act.

Vacancies

7.(1)

A vacancy in the membership of the Board arises on

(a)

(b)

(c)

the death or resignation of a member;

the revocation of the appointment of a member; or

the absence of a member from 4 consecutive meetings of the Board
without the approval of the Minister.

A person who is appointed to fill a vacancy referred to in sub-paragraph
(2)
(1)  shall  hold  office  only  for  the  unexpired  portion  of  the  term  of  the  former
member.

Disqualification of a member

8.

A person who

(a)

(b)

(c)

is a member of Parliament;

is a public officer; or

were he a member, would have to be removed from office pursuant to
paragraph 6,

is not eligible to be a member.

Gazetting of appointments

9.
member shall be published in the Official Gazette.

The  appointment,  resignation,  death  or  removal  from  office  of  a

40

Seal and execution of documents

10.(1)

The seal of the Authority shall be

(a)

kept  in  the  custody  of  the  Chairman,  or  the  person  performing  the
functions of secretary to the Board and may be affixed to documents
or instruments pursuant to a resolution of the Board, in the presence of
any 2 of the persons referred to in this sub-paragraph; and

(b)

authenticated  by  the  signature  of  the  Chairman  or  the  person
performing the functions of secretary to the Board.

All documents or instruments made by the Board, other than those required
(2)
by law to be under seal, and all decisions of the Board shall be signified under
the hand of the Chairman, or the person performing the functions of secretary to
the Board.

Committees

11.(1)
to assist it with the proper discharge of its functions.

The Board may appoint committees of its members or other persons

(2)
Where  a  person  who  is  not  a  member  of  the  Board  is  appointed  to  a
committee,  the  Board  may,  with  the  approval  of  the  Minister,  determine  the
remuneration and allowances to be paid to the person.

Meetings

12.(1)
The Board shall meet as often as may be necessary or expedient for
the transaction of its business and such meetings shall be held at such places and
times and on such days as the Board may determine.

The Chairman, or in the event of his absence from Barbados or inability
(2)
to  act  as  such,  the  person  acting  as  Chairman,  may  at  any  time  call  a  special
meeting of the Board and shall call such a meeting within 7 days of the receipt
by him of a request for the purpose addressed to him in writing and signed by not
less than 3 members.

41

The  Chairman,  or  in  his  absence,  the  person  acting  as  Chairman,  shall

(3)
preside at all meetings of the Board.

Where the Chairman is absent from a meeting, the members present shall

(4)
elect a member from among their number to preside at the meeting.

(5)

Five members shall constitute a quorum.

The decisions of the Board shall be by a majority of votes and in a case
(6)
where the voting is equal, the Chairman or other person presiding at the meeting
shall, in addition to an original vote, have a casting vote.

Minutes  of  each  meeting  shall  be  kept  by  the  person  performing  the
(7)
functions of secretary to the Board or by such other officer as the Board appoints
for the purpose and shall be confirmed by the Board and signed by the Chairman
at the next meeting of the Board.

Attendance of non-members at meetings

The Board may invite any person to attend any of its meetings to assist
13.
or advise it with respect to any matter under its consideration, but a person so
invited does not have a right to vote.

Board may regulate proceedings

14.
regulate its own proceedings.

Subject  to  the  provisions  of  this  First  Schedule,  the  Board  may

42

SECOND SCHEDULE

Barbados Medicinal Cannabis Appeals Tribunal

(Section 38(2))

Appointment of members

The Minister shall by an instrument in writing appoint 3  persons to
1.(1)
be  to  be  members  of  the  Barbados  Medicinal  Cannabis  Appeals  Tribunal,
hereinafter referred to as the Tribunal.

One  of  the  members  appointed  pursuant  to  paragraph  (1)  shall  be  an

(2)
attorney-at-law of at least 10 years standing.

The other 2 members   shall be persons who in the opinion of the Minister,
(3)
have such expertise as may be required for the discharge of the functions of the
Tribunal.

(4)

A member of the Tribunal shall

(a)

(b)

hold office for a term not exceeding 3 years; and

be eligible for reappointment.

Resignation, temporary absence and disqualification

2.
Tribunal as those paragraphs apply to a member of the Board.

Paragraphs  3  to  9  of  the  First  Schedule  apply  to  a  member  of  the

Institution of appeal

3.(1)
An  appeal  to  the  Tribunal  shall  be  instituted  by  filing  with  the
Tribunal,  within  such  time  as  may  be  stipulated  in  the  relevant  specified
enactment, a notice of appeal together with such copies thereof as the Tribunal
may require, and the notice shall state the precise grounds of appeal.

43

(2)
The Chairman of the Tribunal shall set the place, date and time for the
hearing of the appeal and shall notify the parties of the place, date and time at
least 7 days before the date set for the hearing.

Procedure on appeal

4.(1)

The appeal shall be held in camera and

(a)

the parties may appear in person or may be represented by an attorney-
at-law or an agent; and

(b)

the onus of proof is on the appellant.

An  appeal  may  be  heard  in  the  absence  of  a  party  who  has  been  given

(2)
reasonable notice in writing to attend.

In  determining  the  appeal,  the  Tribunal  may  review  the  whole  case  in
(3)
respect of the law and fact, exercise any discretion, and shall determine the case
in accordance with its own judgment.

In the case of a difference of opinion among members sitting together, the
(4)
opinion of the majority shall prevail, and in case of an equality of numbers, the
opinion of the Chairman shall prevail.

Notwithstanding sub-paragraph (4), where the question to be determined
(5)
is one of law, account shall not be taken of the opinion of a member who is not
an attorney-at-law.

Powers of Tribunal

5.(1)

The Tribunal

(a)

may

(i)

issue subpoenas,

(ii)

make orders and give directions to such persons in such manner
as it thinks fit

(A)

for the purpose of summoning witnesses;

44

(B)

for requiring the disclosure of documents or other evidence;

(C)

for requiring parties or witnesses to answer questions;

(D)

for the purpose of conducting its proceedings in a proper and
orderly manner;

(b)

(c)

may,  consult  any  person  having  experience  in  any  relevant  field  in
order to assist it with a matter; and

shall, with respect to the attendance and examination of witnesses, the
production and inspection of documents and all other matters necessary
for the exercise of its jurisdiction, have all such powers as are vested
in a magistrate’s court in an action in that court.

(2)

In the hearing and determination of any matter before it, the Tribunal

(a)

(b)

(c)

(d)

may act without regard to technicalities and legal form;

shall  not  be  bound  to  follow  the  rules  of  evidence  stipulated  in  the
Evidence Act, Cap. 121;

may inform itself on any matter in such manner as it thinks just; and

may take into account opinion evidence and such facts as it considers
relevant and material,

but in any such case, the parties to the proceedings shall be given the opportunity,
if they so desire, of adducing evidence.

Decisions of Tribunal

6.(1)
The  decision  of  the  Tribunal  shall  be  in  writing  and  shall  include
reasons  for  the  decision,  a  statement  of  the  Tribunal’s  findings  on  material
questions of fact and a reference to the evidence or other material on which the
findings are based.

The Tribunal shall ensure that the decision is served on each party to the

(2)
proceedings.

45

Meetings of Tribunal

7.
procedure.

Subject to this Second Schedule, the Tribunal may regulate its own

46

THIRD SCHEDULE

Consequential Amendments

(Section 43)

Enactment

Drug Abuse (Prevention and Control) Act,
Cap. 131

Amendment

Section 2 is amended by

Customs (List of Prohibited and Restricted
Imports and Export) Order, 2009
(S.I. 2009 No. 127)

(a) deleting the definition of cannabis and
substituting the following:
“ cannabis” means any plant of the genus
Cannabis from which the resin has not been
separated and includes any part of that plant by
whatever name it may be designated but does
not include medicinal cannabis;” and

(b) inserting the following definition in the
appropriate alphabetical order:

“medicinal cannabis” has the meaning assigned
to it by section 2 of the Medicinal Cannabis
Industry Act, 2019 (Act 2019- );

Paragraph 2 of Part II of the First Schedule is
deleted and the following is substituted:

“ Cannabis Satvia etc.
2. Cannabis sativa ( know as Indian hemp or
bhang), Cannabis indicia, or any preparation or
mixture thereof, except
(a) under a licence issued by the Chief Medical
Officer; or
(b) in accordance with the provisions of
Medicinal Cannabis Industry Act, 2019.

MEDICINAL CANNABIS INDUSTRY BILL, 2019

EXPLANATORY MEMORANDUM

The This Bill would provide for

(a)

(b)

the regulation of the handling of medicinal cannabis in Barbados;

the  establishment  of  the  Barbados  Medicinal  Cannabis  Licensing
Authority, the Barbados Medicinal Cannabis Licensing Board, and the
Barbados Medicinal Cannabis Appeals Tribunal;

(c)

the issuing of licences for the handling of medicinal cannabis; and

(d)

related matters.

PART IPRELIMINARY

Clause 1:

provides a short tile for citing the Act.

Clause 2:

defines certain words which are to guide the interpretation of
the Act.

PART II: BARBADOS MEDICINAL CANNABIS AUTHORITY

Clause 3:

establishes  the  Authority  as  a  statutory  corporation  to
facilitate the regulation and building of a medicinal cannabis
industry in Barbados.

Clause 4:

states the functions of the Authority.

i

Medicinal Cannabis Industry Bill, 2019

Clause  5:

provides  a  Board  appointed  by  the  Minister  to  manage  the
Authority.

Clause 6:

states the functions of the Board.

Clause 7:

Clause 8:

Clause 9:

Clause 10:

Clause 11:

Clause 12:

Clause 13:

provides  for  the  Board  to  delegate  certain  functions  to  the
Chief Executive Officer of the Authority.

provides for members of the Board to disclose their interest
in  any  contractual  or  related  matter  which  falls  to  be
considered by the Board and where such a disclosure is made
that Board member cannot participate in the deliberation or
the decision taken by the Board.

the  Minister

makes  provision  for
to  request  written
information  on  the  operation  of  the  Authority  and  to  give
direction where this is required in the public interest, so the
Minister  can  ensure  that  the  Authority  is  acting  in  the  best
interest of the citizens of Barbados.

provides for the Board to keep the Minister up to date on how
the Authority is functioning;

provides for a chief Executive Officer to manage the day to
day operations of the Authority, and for the Authority to have
the staff it will need.

provides for public servants to be seconded to the Authority
if this is necessary.

makes it clear that the Board cannot vary the remuneration
paid under the Act.

ii

Medicinal Cannabis Industry Bill, 2019

Clause 14:

states the functions of the Chief Executive Officer.

Clause 15:

Clause 16:

imposes a strict duty of secrecy and confidentiality on the staff
and people involved with the Board or the Authority.

offers  protection  from  personal  liability  for  the  staff  of  the
Authority or members of the Board or Tribunal.

Clause 17:

states how the Authority is to be funded.

Clause 18:

provides a limitation on the statutory powers of the Authority,
as the Authority can only borrow money with the approval of
the Minister.

Clause 19:

provides for the Government to guarantee loans where this is
required.

Clause 20:

requires that the Authority keeps proper accounts.

Clause 21:

Clause 22:

Clause 23:

Clause 24:

requires  the  submission  of  monthly  statements  to  the
Accountant- General.

provides  for  Auditor-General  to  be  the  auditor  of  the
Authority.

provides for the Authority and the Board to be subject to the
Public Finance Management Act, 2019.

requires the Board to submit annual report giving a detailed
assessment on how the Authority functioned over the year.

iii

Medicinal Cannabis Industry Bill, 2019

PART III: ACCESS TO MEDICINAL CANNABIS

Clause 25:

Clause 26:

Clause 27:

provides  for  the  use  of  medicinal  cannabis  under  a  strict
regime which will be fully prescribed in regulations.

restricts the amount of medicinal cannabis a patient may have
at one time.

provides for the medical practitioner to keep medical records
of  all  patients  given  medicinal  cannabis  so  they  can  be
properly  monitored.  This  information  is  usually  kept  by  a
medical  practitioner  and  shall  remain  confidential  but  the
Authority will be entitled to statistical information which does
not  identify  a  patient  beyond  usage  of  medicinal  cannabis,
impact of the usage medicinal cannabis, condition and gender.

Clause 28:

provides for caregivers, as many patients may not be able to
get  their  medication  on  their  own.  It  also  provides  for  the
regulation  of  the  kind  of  person  who  can  be  a  caregiver  to
reduce the likelihood of patient not receiving their medication
and necessary care.

Clause 29:

provides for the manner by which medicinal cannabis will be
dispensed, and this will be by pharmacy or therapeutic facility
and  provides  for  the  kind  of  information  which  must
accompany medicinal cannabis issues to a patient.

iv

Medicinal Cannabis Industry Bill, 2019

PART IV: LICENSING THE SUPPLY OF MEDICINAL CANNABIS

Clause 30:

Clause 31:

Clause 32:

Clause 33:

Clause 34:

Clause 35:

Clause 36:

Clause 37:

gives  the  categories  of  licences  which  will  exist  in  the
industry.

gives details about each type of licence and makes it clear that
a  single  person  may  have  multiple  licences  to  build  their
business.

makes provision for the kind of person who can apply for a
licence.

provides for conditions to attached to licences where this may
be required.

provides for the duration of each kind of licence and makes it
clear that renewal is not automatic so that the performance of
the person granted the licence can be assessed. This does not
alter the usual renewal procedure or business productivity or
growth but serves as a form of legal notification to prevent a
person  developing  a  legitimate  expectation  or  proprietary
right to renewal which can create legal complications in event
that a person is a person whose licence should not be renewed
because that person is in contravention of the Act or in breach
of the granted licence.

makes it an offence to be involved in the medicinal cannabis
industry without a licence.

provides for suspension or revocation of a licence where this
may be necessary.

makes  a  declaration  that  a  person  acting  under  this  Act  or
under a licence issued thereunder is not subject to criminal
liability for the authorised activities under the Act.

v

Medicinal Cannabis Industry Bill, 2019

PART V: BARBADOS MEDICINAL CANNABIS APPEALS TRIBUNAL

Clause 38:

establishes a Tribunal to hear matters under the Act.

Clause 39:

outlines the basic procedure for going before the Tribunal.

PART VI: OFFENCES

Clause 40:

provides for certain general offences.

Clause 41:

provides the penalty for these general offences.

PART VI: MISCELLANEOUS

Clause 42:

provides for detailed regulations to be made to ensure proper
regulation of the use of medicinal cannabis.

Clause 43:

provides for the Schedules to be amended by order.

Clause 44:

provides for consequential amendments.

Clause 45:

provides for the Act come into operation on a date to be fixed
by Proclamation.

vi

